v3.26.1
Group Information - Summary of Information about Entity with Significant Influence Over Group (Details)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
BioNTech | Medine GmbH    
Disclosure of subsidiaries [line items]    
Ownership of ordinary shares in BioNTech (in %) 15.97% 16.85%